ANTIGENIC RESPONSE TO INFLUENZA VIRUS IN MAN .2. NEUTRALIZING ANTIBODY RESPONSE TO INACTIVATED MONOVALENT B VACCINE, WITH OBSERVATIONS ON VACCINE EFFICACY DURING A SUBSEQUENT TYPE B EPIDEMIC

被引:6
作者
BROWN, P
GAJDUSEK, DC
CHEN, KM
MORRIS, JA
机构
关键词
Antibodies; Antigen-antibody reactions; Immunization; Influenza; vaccine; viruses; Vaccines;
D O I
10.1093/oxfordjournals.aje.a121078
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Brown, P., D. C. Gajdusek, K. M. Chen and J. A. Morris (NIH, Bethesda, Md. 20014). Antigenie response to influenza virus in man. II. Neutralizing antibody response to inactivated monovalent B vaccine, with observations on vaccine efficacy during a subsequent type B epidemic. Amer. J. Epid. 1969, 90: 336-343.-Immunization with one of two inactivated monovalent influenza virus type B vaccines, containing either the Great Lakes/1739/54 or Maryland/1/59 strains, was carried out in the populations of several isolated Pacific Islands for whom historical information and serologic testing had yielded a precise knowledge of earlier exposure, or lack of exposure, to influenza type B. Eighty per cent of people without prior exposure to influenza failed to respond with neutralizing antibody after a single dose of vacdne; the remainder responded at very low levels. A booster injection, given 7 months after the initial dose, uniformly produced a 4-fold or greater rise in homologous antibody, with comparable but usually somewhat lesser rises to all tested heterologous strains, except the distantly related Lee/-/40 strain, to which little or no response occurred. In people who had had a single natural infection 15 years before with influenza type B, the greatest response occurred following the first dose of vacdne, with little or no rise after the booster.Five months after the booster vaccination an epidemic of influenza type B occurred in one of the island populations studied. Neither the incidence of infection nor disease was reduced in the segment of the population given type B vaccine when compared with a control group given type A vaccine. However, a modest reduction in the severity of acute disease in the Great Lakes vaccine group was apparent in a lower incidence of fever, pharyngitis, and gastro-intestinal symptoms, and within a native high school community, of complicating otitis media. © 1969, by THE JOHNS HOPKINS UNIVERSITY.
引用
收藏
页码:336 / +
页数:1
相关论文
共 17 条
[1]  
BARNES R., 1966, Papua New Guinea Medical Journal, V9, P127
[2]   EPIDEMIC A2 INFLUENZA IN ISOLATED PACIFIC ISLAND POPULATIONS WITHOUT PRE-EPIDEMIC ANTIBODY TO INFLUENZA VIRUS TYPES A AND B AND DISCOVERY OF OTHER STILL UNEXPOSED POPULATIONS [J].
BROWN, P ;
GAJDUSEK, DC ;
MORRIS, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1966, 83 (01) :176-&
[3]   ANTIGENIC RESPONSE TO INFLUENZA VIRUS IN MAN .I. NEUTRALIZING ANTIBODY RESPONSE TO INACTIVATED MONOVALENT A2 VACCINE AS RELATED TO PRIOR INFLUENZA EXPOSURE [J].
BROWN, P ;
GAJDUSEK, DC ;
MORRIS, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 90 (04) :327-&
[4]  
DAVENPORT F, 1961, AM REV RESPIR DIS, V83, P146
[5]  
DESTGROTH SF, IN PRESS
[6]  
DULL HB, 1966, OCT DIV BIOL STAND C, P7
[7]  
MASCOLI CC, 1966, P SOC EXP BIOL MED, V123, P952, DOI 10.3181/00379727-123-31647
[8]   EVALUATION OF MONOVALENT AND POLYVALENT INFLUENZA VACCINES DURING AN EPIDEMIC OF TYPE A2 AND B INFLUENZA [J].
MAYNARD, JE ;
DULL, HB ;
HANSON, ML ;
FELTZ, ET ;
BERGER, R ;
HAMMES, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1968, 87 (01) :148-&
[9]   IMMUNITY TO INFLUENZA AS RELATED TO ANTIBODY LEVELS [J].
MORRIS, JA ;
KASEL, JA ;
SAGLAM, M ;
KNIGHT, V ;
LODA, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (10) :527-&
[10]  
SALK JE, 1945, J CLIN INVEST, V24, P547, DOI 10.1172/JCI101634